Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules

Pharmaceutical Research

Volumn 31, Issue 7, 2014, Pages 1753-1765

  Groo, Anne Claire ^a,b   Mircheva, Kristina ^c   Bejaud, Jérôme ^a   Ailhas, Caroline ^b   Panaiotov, Ivan ^c   Saulnier, Patrick ^a   Ivanova, Tzvetanka ^c   Lagarce, Frederic ^a,d,e  

^a UNIVERSITÉ D'ANGERS   (France)

^b Ethypharm   (France)

^c UNIVERSITY OF SOFIA   (Bulgaria)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e LUNAM Universite   (France)

Author keywords

diffusion; mucus; nanoparticles; oral delivery; paclitaxel

Indexed keywords

CHITOSAN; MACROGOL; NANOCAPSULE; PACLITAXEL; TRIACYLGLYCEROL; ANTINEOPLASTIC AGENT; DRUG CARRIER; MACROGOL DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; ENCAPSULATION; FILTERS AND MEMBRANES; ISOTHERM; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; SWINE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DIFFUSION; METABOLISM; MUCUS; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; SURFACE PROPERTY;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHITOSAN; DIFFUSION; DRUG CARRIERS; MODELS, BIOLOGICAL; MUCUS; NANOCAPSULES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES; SWINE;

EID: 84904267805     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1280-4     Document Type: Article

References (41)

1. Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm. 2006;62(1):52-8.
2. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus. Int J Pharm. 2005;290(1-2):145-54.
3. Mistry A, Glud SZ, Kjems J, Randel J, Howard KA, Stolnik S, et al. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium. J Drug Target. 2009;17(7):543-52.
4. Ezpeleta I, Arangoa MA, Irache JM, Stainmesse S, Chabenat C, Popineau Y, et al. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus. Int J Pharm. 1999;191(1):25-32.
5. Szentkuti L. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J Control Release. 1997;46(3):233-42.
6. Jain S, Kumar D, Swarnakar NK, Thanki K. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials. 2012;33(28):6758-68.
7. Mura S, Hillaireau H, Nicolas J, Kerdine-Romer S, Le Droumaguet B, Delomenie C, et al. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules. 2011;12(11):4136-43.
8. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158-71.
9. Lai SK, O'Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007;104(5):1482-7.
10. Bravo-Osuna I, Vauthier C, Chacun H, Ponchel G. Specific permeability modulation of intestinal paracellular pathway by chitosan- poly(isobutylcyanoacrylate) core-shell nanoparticles. Eur J Pharm Biopharm. 2008;69(2):436-44.
11. Norris DA, Sinko PJ. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci. 1997;63(11):1481-92.
12. Crater JS, Carrier RL. Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport. Macromol Biosci. 2010;10(12):1473-83.
13. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19(6):875-80.
14. Anton N, Gayet P, Benoit JP, Saulnier P. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm. 2007;344(1-2):44-52.
15. Allen TM, Sapra P, Moase E. Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett. 2002;7(2):217-9.
16. Perrier T, Saulnier P, Fouchet F, Lautram N, Benoit JP. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Int J Pharm. 2010;396(1-2):204-9.
17. Peltier S, Oger JM, Lagarce F, Couet W, Benoit JP. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res. 2006;23(6):1243-50.
18. Roger E, Lagarce F, Benoit JP. The gastrointestinal stability of lipid nanocapsules. Int J Pharm. 2009;379(2):260-5.
19. Roger E, Lagarce F, Garcion E, Benoit JP. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release. 2009;140(2):174-81.
20. Roger E, Lagarce F, Garcion E, Benoit JP. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. Eur J Pharm Sci. 2010;40(5):422-9.
21. Groo A-C, Saulnier P, Gimel J-C, Gravier J, Ailhas C, Benoit J-P, et al. Fate of Paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomedecine. 2013;8(1):4291-302.
22. Artursson P, Borchardt RT. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res. 1997;14(12):1655-8.
23. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175(3):880-5.
24. Szebeni J. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology. 2005;216(2-3):106-21.
25. Yudin AI, Hanson FW, Katz DF. Human cervical mucus and its interaction with sperm: a fine-structural view. Biol Reprod. 1989;40(3):661-71.
26. Dawson M, Krauland E, Wirtz D, Hanes J. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog. 2004;20(3):851-7.
27. Lieleg O, Vladescu I, Ribbeck K. Characterization of particle translocation through mucin hydrogels. Biophys J. 2010;98(9):1782-9.
28. Lai SK, Suk JS, Pace A, Wang YY, Yang M, Mert O, et al. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials. 2011;32(26):6285-90.
29. Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco- and bioadhesion: Tethered structures and site-specific surfaces. J Control Release. 2000;65(1-2):63-71.
30. Yoncheva K, Guembe L, Campanero MA, Irache JM. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int J Pharm. 2007;334(1-2):156-65.
31. Yoncheva K, Lizarraga E, Irache JM. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci. 2005;24(5):411-9.
32. Larhed AW, Artursson P, Gråsjö J, Björk E. Diffusion of drugs in native and purified gastrointestinal mucus. J Pharm Sci. 1997;86(6):660-5.
33. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16(5):351-80.
34. Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. Eur J Pharm Biopharm. 2012;81(3):514-23.
35. Shi L, Miller C, Caldwell KD, Valint P. Effects of mucin addition on the stability of oil-water emulsions. Colloids Surf B: Biointerfaces. 1999;15(3-4):303-12.
36. Proust JE, Baszkin A, Boissonnade MM. Adsorption of bovine submaxillary mucin on surface-oxidized polyethylene films. J Colloid Interface Sci. 1983;94(2):421-9.
37. Khanvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus. Adv Drug Deliv Rev. 2001;48(2-3):173-93.
38. Minkov I, Ivanova T, Panaiotov I, Proust J, Saulnier P. Reorganization of lipid nanocapsules at air-water interface: I. Kinetics of surface film formation. Colloids Surf B: Biointerfaces. 2005;45(1):14-23.
39. Minkov I, Ivanova T, Panaiotov I, Proust J, Saulnier P. Reorganization of lipid nanocapsules at air-water interface: Part 2. Properties of the formed surface film. Colloids Surf B: Biointerfaces. 2005;44(4):197-203.
40. Pavinatto FJ, Caseli L, Pavinatto A, Dos Santos DS, Nobre TM, Zaniquelli MED, et al. Probing Chitosan and Phospholipid Interactions Using Langmuir and Langmuir-Blodgett Films as Cell Membrane Models. Langmuir. 2007;23(14):7666-71.
41. Silva CA, Nobre TM, Pavinatto FJ, Oliveira Jr ON. Interaction of chitosan and mucin in a biomembrane model environment. J Colloid Interface Sci. 2012;376(1):289-95.